Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Sound Pharmaceuticals Incorporated currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is being handled by 1 distinct examiner, LEE, WILLIAM Y, in 1 distinct art unit. With only 1 pending action in the portfolio, the prosecution focus is entirely limited to this single examiner and art unit. This centralized structure means that the company's current patent office engagement is restricted to a single administrative track.
The busiest examiner for the portfolio is LEE, WILLIAM Y, who is responsible for 1 pending office action. Because there is only 1 distinct examiner and 1 distinct art unit involved, the prosecution strategy does not require coordination across multiple divisions. This concentration suggests a patent portfolio where all active matters are consolidated under a single point of review at the patent office. The presence of 1 pending office action indicates a prosecution pipeline that is currently limited to a single matter. This allows for a response strategy tailored to the specific requirements of the 1 distinct examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, WILLIAM Y | 1 | 48.0% | +34.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18482623 | Methods and Compositions for Treating Psychotic Disorders | LEE, WILLIAM Y | — |
| Art Unit | Apps |
|---|---|
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18482623 | Methods and Compositions for Treating Psychotic Disorders | LEE, WILLIAM Y | 1623 | §103 | Final Rejection | — | Pending | Oct 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSound Pharmaceuticals Incorporated has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
William Y Lee has the most, with 1 of Sound Pharmaceuticals Incorporated's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
